Trial Profile
Fosaprepitant versus Ondansetron for prevention of postoperative nausea and vomiting- orthopedic surgery
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Aug 2015
Price :
$35
*
At a glance
- Drugs Fosaprepitant (Primary) ; Ondansetron (Primary)
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- 03 Aug 2015 Status changed from recruiting to completed as per University Hospital Medical Information Network - Japan.
- 27 Feb 2014 New trial record